Mitsubishi UFJ Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,563
Closed -$128K 1165
2021
Q3
$128K Hold
5,563
﹤0.01% 1095
2021
Q2
$244K Sell
5,563
-2,674
-32% -$149K ﹤0.01% 1070
2021
Q1
$598K Buy
8,237
+2,639
+47% +$187K ﹤0.01% 857
2020
Q4
$242K Buy
5,598
+3,520
+169% +$158K ﹤0.01% 934
2020
Q3
$85K Sell
2,078
-90
-4% -$4.65K ﹤0.01% 978
2020
Q2
$130K Buy
2,168
+468
+28% +$42.9K ﹤0.01% 940
2020
Q1
$128K Buy
1,700
+335
+25% +$38.6K ﹤0.01% 904
2019
Q4
$187K Buy
+1,365
New +$166K ﹤0.01% 883

Other funds holding ORTX

Mitsubishi UFJ Asset Management's ORTX Position: Q4 2021 in Review

Mitsubishi UFJ Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 5,563 shares — an estimated $128K sold.

Mitsubishi UFJ Asset Management first reported a position in ORTX in Q4 2019 and held it in 8 quarters. The position peaked at $598K in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Mitsubishi UFJ Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 5,563 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $128K.
  • Mitsubishi UFJ Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 8 quarters.
  • Mitsubishi UFJ Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $598K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.